BioCentury | May 19, 2020
Emerging Company Profile

Helmed by OrbiMed’s Wang, Inmagene debuts with Phase II autoimmune program

Inmagene emerged from stealth with a clinical psoriasis program from Swedish biotech Affibody. Inmagene emerged from stealth last week with plans to expand the biologics markets in China, starting with a Phase II psoriasis program...
Items per page:
1 - 1 of 1